Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: a propensity matched multicentre research network analysis
CONCLUSION: Poor outcomes of COVID-19 disease were observed in patients with IPF after robust matching of confounders. Our data confirm that patients with IPF constitute a high-risk cohort for poor outcomes related to COVID-19 disease.PMID:34376400 | DOI:10.1136/bmjresp-2021-000969
Source: Respiratory Care - Category: Respiratory Medicine Authors: Syeda Fatima Naqvi Dhairya A Lakhani Amir Humza Sohail James Maurer Sarah Sofka Arif Sarwari Yousaf B Hadi Source Type: research
More News: Cardiology | Chronic Kidney Disease | Coronavirus | COVID-19 | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Heart Disease | Respiratory Medicine | SARS | Urology & Nephrology